(Q37153782)

18 August 2017

1 reference

title

Hepatitis B virus infection and transfusion medicine: science and the occult (English)

1 reference

18 August 2017

1 reference

0 references

1 reference

F Blaine Hollinger

1

1 reference

18 August 2017

1 May 2008

1 reference

18 August 2017

1 reference

18 August 2017

48

1 reference

18 August 2017

5

1 reference

18 August 2017

1001-1026

1 reference

Polymerase chain reaction to detect hepatitis B virus DNA and RNA sequences in primary liver cancers from patients negative for hepatitis B surface antigen

18 August 2017

1 reference

https://api.crossref.org/works/10.1111%2FJ.1537-2995.2008.01701.X

Long-lasting memory T cell responses following self-limited acute hepatitis B

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1537-2995.2008.01701.X

Hepatitis B virus DNA in serum and liver is commonly found in Chinese patients with chronic liver disease despite the presence of antibodies to HBsAg

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1537-2995.2008.01701.X

Hepatitis B virus genetic diversity and its impact on diagnostic assays

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1537-2995.2008.01701.X

Viral dynamics in hepatitis B virus infection

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1537-2995.2008.01701.X

Quantitative analysis of HBV cccDNA from clinical specimens: correlation with clinical and virological response during antiviral therapy

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1537-2995.2008.01701.X

Persistence of cccDNA during the natural history of chronic hepatitis B and decline during adefovir dipivoxil therapy.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1537-2995.2008.01701.X

Intrahepatic levels and replicative activity of covalently closed circular hepatitis B virus DNA in chronically infected patients

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1537-2995.2008.01701.X

The role of envelope proteins in hepatitis B virus assembly

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1537-2995.2008.01701.X

Effects of delayed freezing of liver biopsies on the detection of hepatitis C virus RNA strands

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1537-2995.2008.01701.X

Hepatitis B virus DNA in serum of healthy black African adults positive for hepatitis B surface antibody alone: possible association with recombination between genotypes A and D.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1537-2995.2008.01701.X

Occult hepatitis B virus infection in hematopoietic stem cell donors in a hepatitis B virus endemic area.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1537-2995.2008.01701.X

Deficiencies in the standardization and sensitivity of diagnostic tests for hepatitis B virus

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1537-2995.2008.01701.X

Assessing the impact of HBV NAT on window period reduction and residual risk

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1537-2995.2008.01701.X

Hepatitis B virus (HBV) screening strategy to ensure the safety of blood for transfusion through a combination of immunological testing and nucleic acid amplification testing - Japanese experience

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1537-2995.2008.01701.X

LCR testing for gonorrhoea and chlamydia in population surveys and other screenings of low prevalence populations: coping with decreased positive predictive value

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1537-2995.2008.01701.X

Frequency of HBV DNA detection in US blood donors testing positive for the presence of anti-HBc: implications for transfusion transmission and donor screening

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1537-2995.2008.01701.X

Interpretation of various serological profiles of hepatitis B virus infection

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1537-2995.2008.01701.X

Reduction in risk of hepatitis transmission by heat-treatment of a human Factor VIII concentrate.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1537-2995.2008.01701.X

Significance of antibody to hepatitis B core antigen in blood donors as determined by their serologic response to hepatitis B vaccine.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1537-2995.2008.01701.X

A serologic follow-up of the 1942 epidemic of post-vaccination hepatitis in the United States Army

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1537-2995.2008.01701.X

Hepatitis B virus persistence after recovery from acute viral hepatitis

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1537-2995.2008.01701.X

Persistence of isolated antibodies to woodchuck hepatitis virus core antigen is indicative of occult infection

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1537-2995.2008.01701.X

The hepatitis B virus persists for decades after patients' recovery from acute viral hepatitis despite active maintenance of a cytotoxic T-lymphocyte response.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1537-2995.2008.01701.X

Multicenter evaluation of the VERSANT hepatitis B virus DNA 3.0 assay

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1537-2995.2008.01701.X

Avoiding false positives with PCR

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1537-2995.2008.01701.X

High throughput screening of 16 million serologically negative blood donors for hepatitis B virus, hepatitis C virus and human immunodeficiency virus type-1 by nucleic acid amplification testing with specific and sensitive multiplex reagent in Japan

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1537-2995.2008.01701.X

An international collaborative study to establish a World Health Organization international standard for hepatitis B virus DNA nucleic acid amplification techniques

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1537-2995.2008.01701.X

Superiority of minipool nucleic acid amplification technology for hepatitis B virus over chemiluminescence immunoassay for hepatitis B surface antigen screening

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1537-2995.2008.01701.X

Lack of correlation between HBsAg and HBV DNA levels in blood donors who test positive for HBsAg and anti-HBc: implications for future HBV screening policy

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1537-2995.2008.01701.X

Acute hepatitis B virus infection: relation of age to the clinical expression of disease and subsequent development of the carrier state

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1537-2995.2008.01701.X

Quantification of hepatitis B virus genomes and infectivity in human serum samples

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1537-2995.2008.01701.X

Lengths of hepatitis B viremia and antigenemia in blood donors: preliminary evidence of occult (hepatitis B surface antigen-negative) infection in the acute stage.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1537-2995.2008.01701.X

HBV NAT positive [corrected] blood donors in the early and late stages of HBV infection: analyses of the window period and kinetics of HBV DNA.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1537-2995.2008.01701.X

Occult hepatitis B virus infection: implications in transfusion

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1537-2995.2008.01701.X

Diagnosis of acute and inapparent hepatitis B virus infections by measurement of IgM antibody to hepatitis B core antigen

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1537-2995.2008.01701.X

Isolated hepatitis B core antibody--can response to hepatitis B vaccine help elucidate the cause?

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1537-2995.2008.01701.X

Prevention of perinatally transmitted hepatitis B virus infections with hepatitis B immune globulin and hepatitis B vaccine

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1537-2995.2008.01701.X

Incidence of hepatitis B virus infections in preschool children in Taiwan.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1537-2995.2008.01701.X

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1537-2995.2008.01701.X

Natural history of acute hepatitis B surface antigen-positive hepatitis in Greek adults

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1537-2995.2008.01701.X

Low-molecular-weight IgM antibody to hepatitis B core antigen in chronic infections with hepatitis B virus

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1537-2995.2008.01701.X

Co-occurrence of HBsAg and anti-HBs: Two consecutive infections or a sign of advanced chronic liver disease?

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1537-2995.2008.01701.X

Clinical significance of concurrent hepatitis B surface antigen and antibody positivity

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1537-2995.2008.01701.X

Serologic and clinical outcomes of 1536 Alaska Natives chronically infected with hepatitis B virus

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1537-2995.2008.01701.X

Natural history of chronic HBV infection: a cohort study with up to 12 years follow-up in North Greece (part of the Interreg I-II/EC-project).

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1537-2995.2008.01701.X

Hepatitis B virions isolated with antibodies to the pre-S1 domain reveal occult viremia by PCR in Alaska Native HBV carriers who have seroconverted

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1537-2995.2008.01701.X

Characterization and biological properties of a hepatitis B virus isolated from a patient without hepatitis B virus serologic markers

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1537-2995.2008.01701.X

Transmission of hepatitis B from hepatitis-B-seronegative subjects.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1537-2995.2008.01701.X

Persistence of infectious hepadnavirus in the offspring of woodchuck mothers recovered from viral hepatitis

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1537-2995.2008.01701.X

Donor screening for antibody to hepatitis B core antigen and hepatitis B virus infection in transfusion recipients

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1537-2995.2008.01701.X

Transmission of hepatitis B by transplantation of livers from donors positive for antibody to hepatitis B core antigen. The National Institute of Diabetes and Digestive and Kidney Diseases Liver Transplantation Database

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1537-2995.2008.01701.X

Reactivation of HBV replication in HIV-HBV infected patients.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1537-2995.2008.01701.X

Reactivation of latent hepatitis B virus infection with HIV-related immunosuppression

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1537-2995.2008.01701.X

Properties of hepatitis B virus pre-S1 deletion mutants

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1537-2995.2008.01701.X

Individuals with antibodies against hepatitis B core antigen as the only serological marker for hepatitis B infection: high percentage of carriers of hepatitis B and C virus.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1537-2995.2008.01701.X

Detection of HBs antigen in "anti-HBc alone" positive sera

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1537-2995.2008.01701.X

Persistent hepatitis B virus infection in subjects without hepatitis B surface antigen: clinically significant or purely "occult"?

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1537-2995.2008.01701.X

Epidemiology of HBV infection in Asian blood donors: emphasis on occult HBV infection and the role of NAT.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1537-2995.2008.01701.X

Hepatitis B virus (HBV) DNA screening of blood donations in minipools with the COBAS AmpliScreen HBV test

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1537-2995.2008.01701.X

Detection and characterization of hepatitis B virus of anti-hepatitis B core antigen-reactive blood donors in Quebec with an in-house nucleic acid testing assay

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1537-2995.2008.01701.X

Hepatitis B virus DNA-positive, hepatitis B surface antigen-negative blood donations intercepted by anti-hepatitis B core antigen testing: the Canadian Blood Services experience

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1537-2995.2008.01701.X

Evidence that anti-HBc but not HBV DNA testing may prevent some HBV transmission by transfusion.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1537-2995.2008.01701.X

Frequency and load of hepatitis B virus DNA in first-time blood donors with antibodies to hepatitis B core antigen

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1537-2995.2008.01701.X

Epidemiology of hepatitis B in Europe and worldwide

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1537-2995.2008.01701.X

Anti-hepatits B core antigen testing, viral markers, and occult hepatitis B virus infection in Pakistani blood donors: implications for transfusion practice

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1537-2995.2008.01701.X

Evaluation of a multiplex human immunodeficiency virus-1, hepatitis C virus, and hepatitis B virus nucleic acid testing assay to detect viremic blood donors in northern Thailand.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1537-2995.2008.01701.X

Detection and significance of anti-HBc in the blood bank; preliminary results of a controlled prospective study

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1537-2995.2008.01701.X

Posttransfusion hepatitis B transmitted by blood from a hepatitis B surface antigen-negative hepatitis B virus carrier

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1537-2995.2008.01701.X

A mathematical model to estimate global hepatitis B disease burden and vaccination impact.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1537-2995.2008.01701.X

Post-transfusion fulminant hepatitis B after screening for hepatitis B virus core antibody

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1537-2995.2008.01701.X

Determining the size of non-A, non-B hepatitis virus by filtration

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1537-2995.2008.01701.X

Individual nucleic amplification technology does not prevent all hepatitis B virus transmission by blood transfusion

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1537-2995.2008.01701.X

Transfusion-transmitted hepatitis B virus infection in the UK: a small and moving target

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1537-2995.2008.01701.X

Hepatitis B virus transmission by blood donation negative for hepatitis B surface antigen, antibody to HBsAg, antibody to hepatitis B core antigen and HBV DNA.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1537-2995.2008.01701.X

Infectivity of blood components with low hepatitis B virus DNA levels identified in a lookback program

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1537-2995.2008.01701.X

Report of the monothematic EASL conference on liver transplantation for viral hepatitis (Paris, France, January 12-14, 2006).

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1537-2995.2008.01701.X

Breakthrough of hepatitis B virus escape mutants after vaccination and virus reactivation

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1537-2995.2008.01701.X

Immune suppression as the etiology of failure to detect anti-HBc antibodies in patients with chronic hepatitis B virus infection

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1537-2995.2008.01701.X

Low-level viraemia of hepatitis B virus in an anti-HBc- and anti-HBs-positive blood donor

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1537-2995.2008.01701.X

Infectivity of blood from PCR-positive, HBsAg-negative, anti-HBs-positive cases of resolved hepatitis B infection.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1537-2995.2008.01701.X

HBV vaccination of HCV-infected patients with occult HBV infection and anti-HBc-positive blood donors

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1537-2995.2008.01701.X

International collaborative study proposal for the characterization of occult hepatitis B virus infection identified by nucleic acid or anti-HBc screening

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1537-2995.2008.01701.X

High genetic variability of the group-specific a-determinant of hepatitis B virus surface antigen (HBsAg) and the corresponding fragment of the viral polymerase in chronic virus carriers lacking detectable HBsAg in serum.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1537-2995.2008.01701.X

Transfusion-transmitted HBV infection in an endemic area: the necessity of more sensitive screening for HBV carriers

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1537-2995.2008.01701.X

10.1111/J.1537-2995.2008.01701.X

21 January 2018

Identifiers

DOI

1 reference

18 August 2017

1 reference

PubMed ID

18454738